This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishii, H. Articles by Terada, M. Search for Related Content PubMed PubMed Citation Articles by Ishii, H. Articles by Terada, M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jul 1995, 3664-3671, Vol 15, No. 7
Copyright © 1995, American Society for Microbiology

A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation

H Ishii, T Yoshida, H Oh, S Yoshida and M Terada
Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.

The K-sam gene was originally cloned from KATO-III human gastric cancer cells and is identical to the bek or keratinocyte growth factor (KGF) receptor (KGFR) or fibroblast growth factor receptor 2 gene. K-sam generates several variant transcripts by alternative splicing, and the most abundant K-sam transcript in KATO-III cells was cloned as the K- sam-IIC3 cDNA, which has the KGF-binding motif and a short carboxyl terminus lacking a putative phospholipase C-gamma 1 association site, Tyr-769. The K-sam-IIC3 cDNA was distinct from the K-sam-IIC1 cDNA, which was the same as the previously reported KGFR cDNA. The K-sam-IIC1 product contains a long carboxyl terminus with Tyr-769. K-sam-IIC3 showed greater transforming activity in NIH 3T3 cells than did K-sam- IIC1, and in gastric cancer cell lines in general, the level of K-sam- IIC3 mRNA was greater than that of K-sam-IIC1 mRNA. Here we report that the K-sam-IIC3 product was less autophosphorylated than the K-sam-IIC1 product in NIH 3T3 transfectants. K-sam-IIC3-transfected keratinocytes showed a stronger mitogenic response to KGF than did K-sam-IIC1 transfectants. Moreover, K-sam-IIC3-transfected L6 myoblast cells hardly differentiated when cultured in differentiation-inducing medium and growth was not significantly affected, while K-sam-IIC1 transfectants showed a differentiated phenotype with a reduced growth rate. These data indicate the difference in the signal transduction mediated by two KGFR-type K-sam variants generated by alternative splicing which might be involved in certain differentiation and carcinogenesis scenarios.

This article has been cited by other articles:

• Finch, P. W., Rubin, J. S. (2006). Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors.. JNCI J Natl Cancer Inst 98: 812-824 [Abstract] [Full Text]  
• Ueda, T., Sasaki, H., Kuwahara, Y., Nezu, M., Shibuya, T., Sakamoto, H., Ishii, H., Yanagihara, K., Mafune, K.-i., Makuuchi, M., Terada, M. (1999). Deletion of the Carboxyl-Terminal Exons of K-sam/FGFR2 by Short Homology-mediated Recombination, Generating Preferential Expression ofSpecific Messenger RNAs. Cancer Res. 59: 6080-6086 [Abstract] [Full Text]  
• Chevet, E., Lemaitre, G., Janjic, N., Barritault, D., Bikfalvi, A., Katinka, M. D. (1999). Fibroblast Growth Factor Receptors Participate in the Control of Mitogen-activated Protein Kinase Activity during Nerve Growth Factor-induced Neuronal Differentiation of PC12 Cells. J. Biol. Chem. 274: 20901-20908 [Abstract] [Full Text]  
• Gillis, P, Savla, U, Volpert, O., Jimenez, B, Waters, C., Panos, R., Bouck, N. (1999). Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J. Cell Sci. 112: 2049-2057 [Abstract]